Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
O

Osmosun SA
F:V05

Watchlist Manager
Osmosun SA
F:V05
Watchlist
Price: 1.255 EUR 20.67%
Market Cap: €22.1m
Write Note Create Alert Ask AI

Wall St Price Targets

V05 Price Targets Summary
Osmosun SA

Wall Street analysts forecast V05 stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for V05 is 0.309 EUR with a low forecast of 0.306 EUR and a high forecast of 0.318 EUR.

V05 Lowest Forecast
Wall Street Target
€0.306
-76% Downside
V05 Average Forecast
Wall Street Target
€0.309
-75% Downside
V05 Highest Forecast
Wall Street Target
€0.318
-75% Downside
Lowest Forecast
Price Target
0.306 EUR
76% Downside
Average Forecast
Price Target
0.309 EUR
75% Downside
Highest Forecast
Price Target
0.318 EUR
75% Downside
Osmosun SA Competitors:
Price Targets
REZI
Resideo Technologies Inc
107% Upside
HOWL
Werewolf Therapeutics Inc
472% Upside
NBP
I-Mab
401% Upside
REZI
Resideo Technologies Inc
107% Upside
HOWL
Werewolf Therapeutics Inc
472% Upside
NBP
I-Mab
401% Upside

Revenue
Forecast

-27% / Year
Past Growth
130% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss
-27% / Year
Past Growth
130% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Over the last 3 years, the compound annual growth rate for Revenue has been -27%. The projected CAGR for the next 2 years is 130%.

What are analyst estimates?

Gross Profit
Forecast

-20% / Year
Past Growth
-76% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
-20% / Year
Past Growth
-76% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 3 years, the compound annual growth rate for Gross Profit has been -20%. The projected CAGR for the next 1 year is -76%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

What are analyst estimates?

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Pre-Tax Income Forecast
is not available for Osmosun SA

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

What are analyst estimates?

Continue V05 Research

Summary
V05 intrinsic value, competitors valuation, and company profile.
DCF Valuation
V05 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
V05 stock valuation using valuation multiples.
Wall St Estimates
V05 price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
V05 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Osmosun SA listings:
PAR • EUR
ALWTR
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is V05's stock price target?
Price Target
0.309 EUR

According to Wall Street analysts, the average 1-year price target for V05 is 0.309 EUR with a low forecast of 0.306 EUR and a high forecast of 0.318 EUR.

What is the Revenue forecast for Osmosun SA?
Projected CAGR
130%

Over the last 3 years, the compound annual growth rate for Revenue has been -27%. The projected CAGR for the next 2 years is 130%.

What is the Gross Profit forecast for Osmosun SA?
Projected CAGR
-76%

Over the last 3 years, the compound annual growth rate for Gross Profit has been -20%. The projected CAGR for the next 1 year is -76%.

Back to Top
ALPHA SPREAD
Follow us
Join 357,000+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett